help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, M.
Right arrow Articles by Tan, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, M.
Right arrow Articles by Tan, E. M.
(American Journal of Pathology. 2001;159:945-953.)
© 2001 American Society for Investigative Pathology


Regular Articles

Aberrant Expression of Fetal RNA-Binding Protein p62 in Liver Cancer and Liver Cirrhosis

Maolong Lu*, Robert M. Nakamura{dagger}, E. DuBose Dent{dagger}, Jian-Ying Zhang*, Finn C. Nielsen{ddagger}, Jan Christiansen§, Edward K. L. Chan* and Eng M. Tan*

From the Department of Molecular and Experimental Medicine,*
The Scripps Research Institute, and the Department of Pathology,{dagger}
The Scripps Clinic, La Jolla, California; and the Department of Clinical Biochemistry{ddagger}
and RNA Regulation Center,§
Institute of Molecular Biology, University of Copenhagen, Copenhagen, Denmark

p62 is a RNA-binding protein that was isolated by immunoscreening a cDNA expression library with autoantibodies from patients with hepatocellular carcinoma (HCC). This autoantigen binds to mRNA encoding insulin-like growth factor II, which has been found to be overexpressed in HCC and is tumorigenic in transgenic animals. Immunohistochemical analysis of HCC liver showed that 33% (9 of 27) exhibited readily detectable staining of p62 protein in the cytoplasm of all malignant cells in cancer nodules, whereas it was undetectable in adjacent nonmalignant liver cells. In addition one of two patients with cholangiocarcinoma expressed p62 in malignant bile duct epithelial cells. p62 expression was also detected in scattered cells in cirrhotic nodules in contrast to uniform expression in all cells in HCC nodules. In HCC nodules, p62 mRNA was also detected by reverse transcriptase-polymerase chain reaction analysis. Nine normal adult livers did not contain detectable p62 mRNA or p62 protein whereas five fetal livers were all positive for mRNA and protein. The observations show that p62 is developmentally regulated, expressed in fetal, but not in adult liver, and aberrantly expressed in HCC and could be playing a role in abnormal cell proliferation in HCC and cirrhosis by modulating expression of growth factors such as insulin-like growth factor II.





This article has been cited by other articles:


Home page
Mol Cancer ResHome page
I. Cleynen, J. R. Brants, K. Peeters, R. Deckers, M. Debiec-Rychter, R. Sciot, W. J.M. Van de Ven, and M. M.R. Petit
HMGA2 Regulates Transcription of the Imp2 Gene via an Intronic Regulatory Element in Cooperation with Nuclear Factor-{kappa}B
Mol. Cancer Res., April 1, 2007; 5(4): 363 - 372.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
Y. Natkunam, G. Vainer, J. Chen, S. Zhao, R. J. Marinelli, A. S. Hammer, S. Hamilton-Dutoit, E. Pikarsky, G. Amir, R. Levy, et al.
Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms
Haematologica, February 1, 2007; 92(2): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
C. A. Casiano, M. Mediavilla-Varela, and E. M. Tan
Tumor-associated Antigen Arrays for the Serological Diagnosis of Cancer
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1745 - 1759.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
K. Yaniv, A. Fainsod, C. Kalcheim, and J. K. Yisraeli
The RNA-binding protein Vg1 RBP is required for cell migration during early neural development
Development, December 1, 2003; 130(23): 5649 - 5661.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J.-Y. Zhang, C. A. Casiano, X.-X. Peng, J. A. Koziol, E. K. L. Chan, and E. M. Tan
Enhancement of Antibody Detection in Cancer Using Panel of Recombinant Tumor-associated Antigens
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 136 - 143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.